Cargando…
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Cerebral amyloid angiopathy (CAA) is a cerebrovascular disease directly implicated in Alzheimer’s disease (AD) pathogenesis through amyloid-β (Aβ) deposition, which may cause the development and progression of dementia. Despite extensive studies to explore drugs targeting Aβ, clinical benefits have...
Autores principales: | Tanaka, Masashi, Saito, Satoshi, Inoue, Takayuki, Satoh-Asahara, Noriko, Ihara, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139812/ https://www.ncbi.nlm.nih.gov/pubmed/32183348 http://dx.doi.org/10.3390/ijms21061992 |
Ejemplares similares
-
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2021) -
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2014) -
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
por: Tanaka, Masashi, et al.
Publicado: (2019) -
Cerebral Amyloid Angiopathy Presenting as Massive Subarachnoid Haemorrhage: A Case Study and Review of Literature
por: Saito, Satoshi, et al.
Publicado: (2020) -
Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
por: Inoue, Yasuteru, et al.
Publicado: (2021)